BVF PARTNERS L PIL, Board Member at Kymera Therapeutics (NASDAQ:KYMR), reported a large insider buy on November 6, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that PIL purchased 414,105 shares of Kymera Therapeutics. The total transaction amounted to $5,301,325.
Kymera Therapeutics shares are trading up 7.22% at $15.44 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing ...